1-20 of 40
Keywords: Survival
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Neuroepidemiology 1–8.
Published Online: 14 November 2024
... is the most reliable indicator of PD survival as older onset cases have shorter survival. We report on survival in autopsy-confirmed PD cases with onset age <70 years treated with LD and compare that with similar onset-age cases of PD before the discovery of LD. Material and Methods: The Saskatchewan...
Journal Articles
Neuroepidemiology (2023) 57 (5): 345–354.
Published Online: 07 August 2023
...Yannick Béjot; Valentin Pinguet; Gauthier Duloquin Introduction: Understanding the influence of preexisting cognitive impairment on the poststroke outcome is a critical challenge in the context of current aging and growing population. This study aimed to assess long-term survival of patients...
Journal Articles
Neuroepidemiology (2023) 57 (4): 238–245.
Published Online: 03 July 2023
... Karelia. Genetic testing had been conducted in 28% of all patients with the most common findings being SOD1 and C9orf72 . After the diagnosis, mean survival was 2.0–2.7 and median survival 1.3–1.4 years. Onset phenotype ( p < 0.001), age at diagnosis ( p < 0.001), and genotype ( p = 0.001) predicted...
Journal Articles
Neuroepidemiology (2022) 56 (2): 90–96.
Published Online: 22 December 2021
... physician encounters with reference to longer term outcomes. We aimed to compare methods for measuring regularity and continuity of PCP encounters, based on survival following stroke using linked healthcare data. Methods: Data from the Australian Stroke Clinical Registry (2010–2014) were linked...
Journal Articles
Neuroepidemiology (2021) 55 (1): 56–61.
Published Online: 18 February 2021
...Tanya Gurevich; Ludmila Merkin; Alina Rozenberg; Ariel Fisher; Elly Atanasova Mishkova-Serafimova; Dina Klepikov; Nir Giladi; Chava Peretz Objective: The aim of this study is to estimate survival among patients with multiple system atrophy-parkinsonian type (MSA-P) or cerebellar type MSA (MSA-C...
Journal Articles
Neuroepidemiology (2020) 54 (5): 375–382.
Published Online: 20 July 2020
... and cardiovascular events. The aim was to investigate survival in patients with RLS. Methods: This was an observational, retrospective longitudinal study of a cohort of patients followed up for 11 years. RLS was diagnosed by a physician using the International RLS Study Group criteria. Mortality was analyzed using...
Journal Articles
Neuroepidemiology (2020) 54 (2): 148–156.
Published Online: 05 February 2020
... a Cox model adjusting for age, sex, income, and comorbidity, to compare survival in immigrants versus long-term residents. Results: There were 23,603 incident MS cases of whom 1,410 (6.0%) were immigrants. After adjusting for covariates, risk of death was higher in immigrants in the first year after...
Journal Articles
Neuroepidemiology (2020) 54 (3): 251–257.
Published Online: 06 December 2019
... prevalence in December 2014 was 4.9/100,000 (95% CI 2.0–7.8), and the incidence was 1.4/100,000/year (95% CI 0.5–2.2). The median survival was 4 years. Spinal-onset was observed in 62.4% of the included patients. Conclusion: Prevalence, incidence and clinical presentation of ALS in Antioquia are similar...
Journal Articles
Neuroepidemiology (2019) 53 (1-2): 13–19.
Published Online: 14 June 2019
...Chava Peretz; Violetta Rozani; Nir Giladi; Baruch El-Ad; Judith Tsamir; Beatriz Hemo; Tanya Gurevich Background: To estimate the survival of a population-based cohort of Parkinson’s disease (PD) patients stratified by age and sex over a 13-year period. Methods: The dynamic PD cohort included 6,622...
Journal Articles
Neuroepidemiology (2019) 52 (3-4): 136–143.
Published Online: 18 January 2019
... not related to smoking. Another explanation is survival bias where death from cancer may act as a competing risk. We conducted a large population-based case-control study in Denmark and investigated whether cancer diagnosis reduced the risk of developing PD even after adjusting for important risk factors...
Journal Articles
Neuroepidemiology (2017) 49 (1-2): 64–73.
Published Online: 05 September 2017
... and July 2013, were included. Descriptive and comparative analyses by age group were carried out. For time to event univariate analysis, Kaplan-Meier estimator and log rank test were used. Univariate and multivariate survival analyses were carried out with Cox's proportional hazard model. Results: Out...
Journal Articles
Neuroepidemiology (2016) 47 (2): 76–81.
Published Online: 13 September 2016
... were compared to those of age-sex-matched patients without ALS. Survival after ALS diagnosis was assessed until death and until tracheostomy or death (follow-up through 2014). Results: In 2013 (n = 158), the prevalence of ALS was 8.1 per 100,000 population in MHS. In 1997-2013, a total of 375 ALS...
Journal Articles
Neuroepidemiology (2016) 46 (4): 261–267.
Published Online: 15 March 2016
... medical record review, we narrowed our sample to 115 patients who fulfilled the criteria for probable MSA. We recorded clinical features, examined differences by MSA subtype and used Kaplan-Meier survival analysis to examine mortality. Results: The mean age at onset of patients with probable MSA was 60.2...
Journal Articles
Journal Articles
Neuroepidemiology (2016) 46 (1): 14–23.
Published Online: 19 November 2015
... also presenting an illustrative case. Methods: The SEER database was queried for cases of spinal hemangioblastoma between 2000 and 2010 with the use of SEER*Stat software. Incidence was evaluated as a function of age, sex and race. Survival was evaluated with the Cox proportionate hazards ratio using...
Journal Articles
Neuroepidemiology (2015) 44 (3): 182–198.
Published Online: 13 May 2015
.... The combined estimate for low- and middle-income countries was nearly three times higher than for high-income countries. Pooled estimates of first-year survival were 86.5% (95% CI 75.3-93.1), 95.6% (95% CI 81.0-99.1), and 94.0% (95% CI 93.3-94.6) in the Americas, Europe and Western Pacific. Pooled estimates...
Journal Articles
Neuroepidemiology (2015) 44 (3): 149–155.
Published Online: 21 April 2015
...Joachim Wolf; Anton Safer; Johannes C. Wöhrle; Frederick Palm; Wilfred A. Nix; Matthias Maschke; Armin J. Grau Background: The possibility to survive with amyotrophic lateral sclerosis (ALS) varies considerably and survival extends from a few months to several years. A number of demographic...
Journal Articles
Neuroepidemiology (2015) 44 (1): 1–5.
Published Online: 07 January 2015
... study of RTT performed in Serbia with an aim to estimate prevalence, incidence and survival of patients with this disorder in our country. [email protected] 31 07 2014 2 11 2014 7 1 2015 © 2015 S. Karger AG, Basel 2015 Copyright / Drug Dosage / Disclaimer...
Journal Articles
Journal Articles
Neuroepidemiology (2013) 41 (1): 20–28.
Published Online: 19 March 2013
...F. Delva; C. Pimouguet; C. Helmer; K. Péres; B. Bréchat; M. Le Goff; H. Jacqmin-Gadda; H. Amieva; J.-M. Orgogozo; S. Auriacombe; C. Berr; C. Tzourio; P. Barberger-Gateau; J.F. Dartigues Background/Aims: This study was designed to develop a practical risk score for predicting 5-year survival after...